Biomarker detects, regulates brain tumors

Nov 16, 2006

U.S. cancer researchers have identified a biomarker for brain tumors that also regulates the spread of intercranial tumors.

The Emory University scientists, in collaboration with researchers at the Dana Farber Cancer Institute, found the biomarker -- soluble attractin -- is elevated in the cerebrospinal fluid of patients with malignant astrocytoma, the most common form of brain tumors, and mediates glioma cell migration.

The biomarker is normally absent in the central nervous system and is undetectable in cerebral spinal fluid unless malignant astrocytomas are present in the CNS, the scientists said.

The discovery means physicians will have a new minimally invasive method to track the success of treatments, said Erwin Van Meir, professor of neurosurgery and lead author of the study.

He said the biomarkers, singly or in combination, will provide a fingerprint of the disease and be able, in the future, to better define the disease, suggest what kind of treatment to use and allow physicians to monitor how well the tumor responds to treatment.

The research is published in the November issue of the journal Clinical Cancer Research.

Copyright 2006 by United Press International

Explore further: A new way to diagnose malaria, using magnetic fields

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

A new way to diagnose malaria, using magnetic fields

14 hours ago

Over the past several decades, malaria diagnosis has changed very little. After taking a blood sample from a patient, a technician smears the blood across a glass slide, stains it with a special dye, and ...

How Alzheimer's peptides shut down cellular powerhouses

Aug 29, 2014

The failing in the work of nerve cells: An international team of researchers led by Prof. Dr. Chris Meisinger from the Institute of Biochemistry and Molecular Biology of the University of Freiburg has discovered ...

User comments : 0